C.M. Bidwell & Associates’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

C.M. Bidwell & Associates’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.1K	Hold	75	–	–	0.01%	269
2025 Q4	$15.5K	Hold	75	–	–	0.01%	266
2025 Q3	$13.4K	Hold	75	–	–	0.01%	275
2025 Q2	$12.1K	Hold	75	–	–	0.01%	273
2025 Q1	$12.8K	Hold	75	–	–	0.01%	266
2024 Q4	$12.5K	Hold	75	–	–	0.01%	274
2024 Q3	$12.9K	Hold	75	–	–	0.01%	272
2024 Q2	$11.5K	Hold	75	–	–	0.01%	277
2024 Q1	$11.5K	Hold	75	–	–	0.01%	281
2023 Q4	$11.9K	Hold	75	–	–	0.01%	291
2023 Q3	$11K	Hold	75	–	–	0.01%	354
2023 Q2	$11.5K	Hold	75	–	–	0.01%	366
2023 Q1	$11.6K	Hold	75	–	–	0.01%	361
2022 Q4	$11.6K	Hold	75	–	–	0.01%	351
2022 Q3	$10K	Hold	75	–	–	0.01%	349
2022 Q2	$10K	Hold	75	–	–	0.01%	347
2022 Q1	$11K	Hold	75	–	–	0.01%	358
2021 Q4	$12K	Hold	75	–	–	0.01%	376
2021 Q3	$12K	Buy	+75	New	+$12.8K	0.01%	378

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

C.M. Bidwell & Associates's FBT Position: Q1 2026 in Review

C.M. Bidwell & Associates held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q1 2026 at 75 shares worth $15.1K. The position accounts for 0.01% of the portfolio, ranked #269.

C.M. Bidwell & Associates first reported a position in FBT in Q3 2021 and has held it in 19 quarters since. The position peaked at $15.5K in Q4 2025. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

C.M. Bidwell & Associates held 75 shares of First Trust NYSE Arca Biotechnology Index Fund worth $15.1K as of Q1 2026.
C.M. Bidwell & Associates left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q1 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of C.M. Bidwell & Associates's portfolio in Q1 2026, its #269 holding.
C.M. Bidwell & Associates first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2021 and has held it in 19 quarters since.
C.M. Bidwell & Associates's First Trust NYSE Arca Biotechnology Index Fund position peaked at $15.5K in Q4 2025.
307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2026, filed 15 May 2026.